Why 87% of regulated labs ban public AI, how €18K/month per team is lost to insecure workflows, and how custom-trained secure models fix it.
A typical 8-person chemistry/pharma deep-tech startup in Vilnius. €1.2M seed-funded, 3 ongoing projects, GMP-scale ambitions. They are regulated, resource-constrained, and desperate for AI - but trapped in 1990s workflows.
The problem, hour by hour
Team gathers around physical lab notebooks - paper only, no digital backup. Yesterday's results are handwritten: reaction yields, pH logs, spectral data sketches. SOPs live in three-ring binders on a shelf.
Task assignment via Trello free tier - cards contain links to proprietary chemical formulas and patient-derived assay data on non-EU servers.
CEO's Pain
Scientist runs synthesis in fume hood. Every measurement, observation and deviation recorded on paper - GLP requirement. Photos taken with phone, manually transferred to a local Windows share with no version control.
Scientists dream of domain-specific models trained on their own data - predictive reaction yields, catalyst suggestions - but have no secure way to retrain.
Time Wasted
"Where did we run this exact protocol last month?" - no search, no AI assistant allowed.
Paper notes manually transcribed into Excel/Google Sheets - shared insecurely. Team wants AI help: "Summarize yield trends, suggest next catalyst."
Blocked. Company policy bans ChatGPT, Claude, Gemini. One accidental upload = IP theft risk + audit failure. Internal attempt with open-source Ollama → crashes on laptop GPU, no collaborative UI, zero domain knowledge.
Scientist Benefit Lost
Scale-up discussion with manufacturing partner. Need to generate a GMP-compliant batch record draft + risk assessment. Current process: copy-paste from old Word docs + manual formatting → 4 hours per document.
Compliance officer flags "data residency violation" in Trello - again.
CEO's Afternoon Crisis
Team has 6 months of proprietary reaction data - patentable chemistry + laser-physics parameters. They want to fine-tune a domain model for reaction prediction.
Quantified Pain
Paper notebooks scanned to local NAS - no RAG, no audit trail. Tomorrow starts from scratch. CEO closes the day with zero automated progress report or roadmap update.
The weekly reality check
of researcher time on
admin/paperwork instead of science
lost productivity per lab
(8-person team, EU salary)
GDPR fine from a single
data-leak event
leverage while US/Asia
competitors move 10× faster
This is not a hypothetical. This is every lean regulated lab in EU pharma, biotech, chemistry, and MedTech right now - exactly the 87% that ban public AI tools.
The business problem - in one sentence
Lean EU R&D teams are drowning in paper + insecure tools, forbidden from using modern AI, and physically unable to retrain models on their own IP - while CEOs lack transparency and roadmap generation - creating a €280M SOM gap that IngenLab fills with one private platform.
The IngenLab solution
Scan paper notebook → automatic private OCR → instant RAG in owned knowledge base. Search 6 months of experiments in seconds, not minutes.
Secure, EU-hosted task management + Claude-like cowork sessions with built-in progress dashboards. Zero data leaves the enclave. Real-time visibility for investors.
Select dataset → Gradient GPUs spin up in EU DC → new domain model ready in <2 hours, fully owned, zero exposure. Scientists immediately benefit with predictive AI tailored to their lab.
CEO asks "Generate Q3 roadmap from current experiments" → gets professional Gantt + risk matrix in seconds, fully auditable. GMP batch records generated in minutes, not hours.
Projected results for LabNova
time freed for
actual R&D
transparency dashboards
& instant roadmaps for CEO
higher experiment success
from daily model retraining
IP stays theirs -
zero vendor lock-in
first domain model live
with measurable yield improvements
EU AI Act compliant
full audit trail from day one
Book a private demo to see how IngenLab turns paper-bound labs into AI-powered R&D teams - in full compliance.
First 50 respondents get the EU Regulated AI Adoption Report 2026 + personal pilot invitation.